Fri09212018

Robins Global News & Noticias



  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • Trump Pence News
    Trump Pence News
  • Weather Alerts
    Weather Alerts

Special News Reports

+ Larger Font | + Smaller Font

Globe NewsWire News Distribution Service

Press Release: Mersana Therapeutics Presents Preclinical Data Further Demonstrating Differentiating Aspects of Its ADC Platform Technology at AACR 2018

Detailed Characterization of Unique DolaLock Technology Enhancements to Drug Efficacy and Tolerability
XMT-1522 Demonstrates Synergy in Combination with a Checkpoint InhibitorCAMBRIDGE, Mass., April 17, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) based on its Dolaflexin and other proprietary platforms, today announced new data on Mersana’s lead ADC platform, Dolaflexin, and on the HER2 targeted ADC XMT-1522, presented as part of the 2018 American Association for Cancer Research (AACR) Annual Meeting bei...


Posted: 2018-04-17 17:01:00

Get Full News Story On GlobeNewsWire Press Release Service


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.






Print Friendly and PDF Share Embed


Related News Stories From The Web And More

Related Bing News

Press Release: Mersana Therapeutics Presents Preclinical Data Further Demonstrating Differentiating Aspects of Its ADC Platform Technology at AACR 2018 | Globe NewsWire News Distribution Service - Newscast

Mersana Therapeutics Presents Preclinical Data Further Demonstrating Differentiating Aspects of Its ADC Platform Technology at AACR 2018

Tue, 17 Apr 2018 10:17:00 GMT

CAMBRIDGE, Mass., April 17, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody d...

Sareum : AACR 2018 Update

Mon, 16 Apr 2018 17:00:00 GMT

Sareum Notes that Sierra Oncology will Present Late-Breaking Data Demonstrating SRA737 Preclinical Activity with PARP Inhibitors at the AACR 2018 Annual Meeting Two ... The Company's drug discovery te...

AACR 2018 Update

Mon, 16 Apr 2018 17:00:00 GMT

Sareum Notes that Sierra Oncology will Present Late-Breaking Data Demonstrating SRA737 Preclinical Activity with PARP Inhibitors at the AACR 2018 Annual Meeting Two ... The Company's drug discovery te...

MabVax Therapeutics Reports 2017 Operational and Financial Results and 2018 Milestones

Mon, 02 Apr 2018 04:44:00 GMT

We look forward to continuing enrollment in each program and participating in key scientific conferences over the course of 2018, including our upcoming presentation of new data at AACR ... to retain ...

Full Year Results

Thu, 29 Mar 2018 00:00:00 GMT

Nature Communications and presented at American Association for Cancer Research (AACR) Annual Meeting in April 2017 further validating its technology ... multiple aspects of Glycotest's proprietary li...

Related Bing Web Search

Pharmaceutical Conferences - Drug Conferences | 2018 | 2019

(Tue, 18 Sep 2018 20:34:00 GMT)

Welcome to The Pharmaceutical Conferences. Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.. Explore and learn more about Conference Series LLC LTD: World’s leading Event Organizer ...

Crown Bioscience Oncology & CVMD Models

(Sun, 16 Sep 2018 07:00:00 GMT)

Presented by Dr Henry Li, this webinar explores the detailed data analysis behind the industry's first large-scale, staggered, syngeneic screening platform for immunotherapy development.

Pharmatest Services Ltd is a CRO offering preclinical ...

(Mon, 17 Sep 2018 19:45:00 GMT)

Pharmatest Services attends Annual Meeting of American Association for Cancer Research (AACR) held in Chicago, Illinois, USA on April 14 – 18, 2018.

BioTek Instruments

(Wed, 19 Sep 2018 13:09:00 GMT)

BioTek Instruments, Inc. is a global leader in the development, manufacture and sale of life science instrumentation, including imaging & microscopy, multi-mode detection, liquid handling and automation systems.

MRSN Stock Price - Mersana Therapeutics Inc. Stock Quote ...

(Sun, 16 Sep 2018 01:31:00 GMT)

Mersana Therapeutics Inc. stock price, stock quotes and financial overviews from MarketWatch.

Dracen Pharmaceuticals

(Thu, 13 Sep 2018 19:28:00 GMT)

about us dracen is a privately-funded biotech company developing drugs in the area of immuno-metabolism. targeting immuno-metabolism promises to have broad acting effects on modulating immune responses in multiple disease settings.

About - Alliance for SoCal Innovation

(Sun, 16 Sep 2018 20:08:00 GMT)

The Alliance for Southern California was created to accelerate the creation of more blockbuster technology and life science companies in SoCal.

GRAIL | Combining Science, Tech and Clinical Studies to ...

(Wed, 19 Sep 2018 09:06:00 GMT)

GRAIL is taking on one of the biggest challenges of our lifetime, combining science, technology, and clinical studies to reveal cancer at its beginnings.

Vividion Therapeutics: Creating a New Era in Drug Discovery

(Mon, 17 Sep 2018 12:21:00 GMT)

Vividion is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome-wide drug and target discovery.

Life extension - Wikipedia

(Fri, 14 Sep 2018 18:37:00 GMT)

Another proposed life extension technology would combine existing and predicted future biochemical and genetic techniques. SENS proposes that rejuvenation may be obtained by removing aging damage via the use of stem cells and tissue engineering, telomere-lengthening machinery, allotopic expression of mitochondrial proteins, targeted ablation of cells, immunotherapeutic clearance, and novel ...

Related News Story Videos From Youtube

An Accessible Proteogenomics Informatics Resource for Cancer Researchers.


Related Videos On: An Accessible Proteogenomics Informatics Resource for Cancer Researchers.


TRACO 2017 - Clinical trials and Precision Medicine


Related Videos On: TRACO 2017 - Clinical trials and Precision Medicine


Mobile and Personal Technologies in Precision Medicine Workshop - July 27-28, 2015 - Day 2


Related Videos On: Mobile and Personal Technologies in Precision Medicine Workshop - July 27-28, 2015 - Day 2


Translating the cancer genome: transforming cancer care


Related Videos On: Translating the cancer genome: transforming cancer care


TRACO 2016: Precision Medicine and Nanotechnology


Related Videos On: TRACO 2016: Precision Medicine and Nanotechnology






Blow Us A Whistle

Comments (Whistles) Designed By Disqus




Company Information

Official Content Providers











PRIVACY POLICY

We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
© 2008-2018 RobinsPost (The Bird's Eye View Company) All rights are reserved.
RobinsPost provides links to news sites based on their RSS feeds.
All trademarks, copyrights, videos, photos and logos are owned by news sources.
News stories, videos and live streams are from trusted sources.
ROBINSPOST Is Proudly Made In America.
Where Quality, Safety and Service Comes First.